Patents by Inventor Shuli Mao

Shuli Mao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO
    Publication number: 20210252033
    Abstract: This disclosure relates to certain N4-hydroxycytidine derivatives, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of human coronavirus 2019-nCoV.
    Type: Application
    Filed: February 8, 2021
    Publication date: August 19, 2021
    Inventors: George R. PAINTER, Gregory R. BLUEMLING, Michael C. NATCHUS, Shuli MAO, Jose MARENGO, Michael W. HAGER, David PERRYMAN
  • Carbapenem antibacterials with gram-negative activity
    Patent number: 9937151
    Abstract: The present invention provides ?-methyl carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment.
    Type: Grant
    Filed: April 22, 2015
    Date of Patent: April 10, 2018
    Assignee: FOB Synthesis, Inc.
    Inventors: Woo-Baeg Choi, Ewa Gruszecka-Kowalik, Hyung-Yeul Joo, Shuangpei Liu, Shuli Mao, Yongfeng Li, Deog-Il Kim
  • Carbapenem Antibacterials with Gram-Negative Activity
    Publication number: 20150306071
    Abstract: The present invention provides ?-methyl carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment.
    Type: Application
    Filed: April 22, 2015
    Publication date: October 29, 2015
    Inventors: Woo-Baeg Choi, Ewa Gruszecka-Kowalik, Hyung-Yeul Joo, Shuangpei Liu, Shuli Mao, Yongfeng Li, Deog-II Kim
  • Carbapenem antibacterials with gram-negative activity
    Patent number: 9149461
    Abstract: The present invention provides ?-methyl carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment.
    Type: Grant
    Filed: December 13, 2012
    Date of Patent: October 6, 2015
    Assignee: FOB Synthesis, Inc.
    Inventors: Woo-Baeg Choi, Ewa Gruszecka-Kowalik, Hyung-Yeul Joo, Shuangpei Liu, Shuli Mao, Yongfeng Li, Deog-Il Kim
  • 2? and 3?-substituted cyclobutyl nucleoside analogs for the treatment viral infections and abnormal cellular proliferation
    Patent number: 8114994
    Abstract: Provided are cyclobutyl nucleosides and methods for their use in treatment of infections including Retroviridae (including HIV), Hepadnaviridae (including HBV), or Flaviviridae (including BVDV and HCV) infection, or conditions related to abnormal cellular proliferation, in a host, including animals, and especially humans.
    Type: Grant
    Filed: February 10, 2009
    Date of Patent: February 14, 2012
    Assignee: Emory University
    Inventors: Dennis C. Liotta, Shuli Mao, Michael Hager, Raymond F Schinazi
  • 2' and 3'-Substituted Cyclobutyl Nucleoside Analogs for the Treatment Viral Infections and Abnormal Cellular Proliferation
    Publication number: 20090149416
    Abstract: Provided are cyclobutyl nucleosides and methods for their use in treatment of infections including Retroviridae (including HIV), Hepadnaviridae (including HBV), or Flaviviridae (including BVDV and HCV) infection, or conditions related to abnormal cellular proliferation, in a host, including animals, and especially humans.
    Type: Application
    Filed: February 10, 2009
    Publication date: June 11, 2009
    Inventors: Dennis C. Liotta, Shuli Mao, Michael Hager
  • 2? and 3?-substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation
    Patent number: 7495006
    Abstract: Provided are cyclobutyl nucleosides and methods for their use in treatment of infections including Retroviridae (including HIV), Hepadnaviridae (including HBV), or Flaviviridae (including BVDV and HCV) infection, or conditions related to abnormal cellular proliferation, in a host, including animals, and especially humans.
    Type: Grant
    Filed: December 8, 2005
    Date of Patent: February 24, 2009
    Assignee: Emory University
    Inventors: Dennis C. Liotta, Shuli Mao, Michael Hager
  • 2' and 3'- substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation
    Publication number: 20060223835
    Abstract: Provided are cyclobutyl nucleosides and methods for their use in treatment of infections including Retroviridae (including HIV), Hepadnaviridae (including HBV), or Flaviviridae (including BVDV and HCV) infection, or conditions related to abnormal cellular proliferation, in a host, including animals, and especially humans.
    Type: Application
    Filed: December 8, 2005
    Publication date: October 5, 2006
    Inventors: Dennis Liotta, Shuli Mao, Michael Hager